Stock Price Quote

PARABOLIC DRUGS LTD.

NSE : PARABDRUGSBSE : 533211ISIN CODE : INE618H01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE3.74-0.19 (-4.83 %)
PREV CLOSE ( ) 3.93
OPEN PRICE ( ) 4.12
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3.74 (24420)
VOLUME 209361
TODAY'S LOW / HIGH ( )3.74 4.12
52 WK LOW / HIGH ( )0.59 3.93
NSE3.000.1 (+3.45 %)
PREV CLOSE( ) 2.90
OPEN PRICE ( ) 3.00
BID PRICE (QTY) 3.00 (67521)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8724
TODAY'S LOW / HIGH( ) 3.00 3.00
52 WK LOW / HIGH ( )0.45 2.95
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 22-02 1996
Management Info
- Chairman Pranav Gupta - Managing Director
Registered Office

Address S.c.o. 186-187,2nd Floor,Sector 8c,
Chandigarh,
Punjab-160017

Phone +91-172-3914646/3914647/38

Email NA

Website www.parabolicdrugs.com

Registrars Details
Link Intime India Pvt Ltd.
Narang Tower 44, Community Centre,Naraina Industrial Area ,Phase - 1,New Delhi
Listing : BSE, NSE, MCX

NEWS

10Apr Parabolic Drugs informs about CoC meet
Parabolic Drugs has informed about outcome of seventh meeting of Committ..
07Mar Parabolic Drugs informs about CoC meet
Pursuant to the provisions of Regulations 17, 19 and 20 of the IBBI (Ins..
05Jan Parabolic Drugs informs about CoC meet
Pursuant to the provisions of Regulations 17, 19 and 20 of the IBBI (Ins..
27Nov Parabolic Drugs informs about CoC meet
Pursuant to the provisions of Regulations 17, 19 and 20 of the IBBI (Ins..
30Oct Parabolic Drugs informs about complian
Pursuant to Regulation 40 of SEBI (Listing Obligations and Disclosure Re..

Financials

in Millions
QTR Jun 19 ANNUAL 19
Net Profit-74.9-406.6
Gross Profit -76.6 -391.9
Operating Profit -19.4-139.4
Net Sales 180.8

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  12680.00 (0.99%)
M.Cap ( in Cr)26944.11
Pfizer (BSE)
peergroup  4320.40 (1.80%)
M.Cap ( in Cr)19785.89
Astrazeneca Pharma I (BSE)
peergroup  2704.85 (1.05%)
M.Cap ( in Cr)6762.13
Procter&Gamble Healt (BSE)
peergroup  4155.00 (0.52%)
M.Cap ( in Cr)6921.94
Dr. Reddys Lab (BSE)
peergroup  2904.80 (0.60%)
M.Cap ( in Cr)48225.84

Shareholding Pattern

NON-INSTITUTION 53.57%
PROMOTERS 37.79%
FI/BANKS/INSURANCE 0.57%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
UTI CCF - Savings Plan0.00

About Parabolic Drugs Ltd.

Parabolic Drugs Ltd. was incorporated in the year 22-02-1996. Its today's share price is 3.93. Its current market capitalisation stands at Rs 23.15 Cr. In the latest quarter, company has reported Gross Sales of Rs. 731.57 Cr and Total Income of Rs.773.16 Cr. The company's management includes Vandana Singla, Jagjit Singh Chahal, Sanjeev Kumar, Vineet Gupta, Pranav Gupta.

It is listed on the BSE with a BSE Code of 533211 , NSE with an NSE Symbol of PARABDRUGS and ISIN of INE618H01016. It's Registered office is at S.c.o. 186-187,2nd Floor,Sector 8cChandigarh-160017, Punjab. Their Registrars are ACC Ltd. It's auditors are SK Bansal & Co, VK Jindal & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X